Skip to main content
SpringerLink
Log in

Recent classification of renal epithelial tumors

  • Award Review
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

The recent classification of renal tumors is based on genetic evidence as well as on histologic features. Malignant tumor includes clear cell renal carcinoma (RCC), multilocular cystic RCC, papillary RCC, chromophobe RCC, carcinoma of the collecting duct of Bellini, renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and mucinous tubular and spindle cell carcinoma. Benign tumor is subdivided into papillary adenoma, renal oncocytoma and metanephric adenoma. Recently, new disease entities such as acquired cystic disease-associated RCC, clear cell papillary RCC and renal carcinoma with t(6;11)(p21:q12) have been discovered. In this article, we briefly review and introduce the clinical, morphological and genetic features of these tumor entities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization Classification of Tumors. Pathology & Genetics. Tumours of the urinary system and male genital organ. IARC press, Lyon

    Google Scholar 

  2. Amin MB, McKenney JK, Tickoo SK, Paner GP, Shen SS, Velazquez EF, Cubilla AL, Ro JY, Reuter VE (eds) (2010) Diagnostic pathology, genitourinary. Amirsys, LWW, Canada

    Google Scholar 

  3. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855

    CAS  PubMed  Google Scholar 

  4. Nagashima Y, Inayama Y, Kato Y, Kanno H, Aoki I, Yao M (2004) Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date. Pathol Int 54:377–386

    Article  PubMed  Google Scholar 

  5. Sükösd F, Kuroda N, Beothe T, Kaur AP, Kovacs G (2003) Deletion of chromosome 3p14.2-p25 involving in the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63:455–457

    PubMed  Google Scholar 

  6. Williamson SR, Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan P-H, Wang M, Zhang S, MacLennan GT, Baldridge LA, Cheng L (2012) Multilocular cystic renal cell carcinoma. Similarities and difference in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36:1425–1433

    Article  PubMed  Google Scholar 

  7. Kuroda N, Ohe C, Mikami S, Inoue K, Nagashima Y, Cohen RJ, Pan CC, Michal M, Hes O (2012) Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27:969–974

    PubMed  Google Scholar 

  8. Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544

    CAS  PubMed  Google Scholar 

  9. Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:487–494

    CAS  PubMed  Google Scholar 

  10. Thoenes W, Störkel S, Rumplet H-J, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variant—a report of 32 cases. J Pathol 155:277–287

    Article  CAS  PubMed  Google Scholar 

  11. Nagashima Y (2000) Chromophobe renal cell carcinoma: clinical, pathological and molecular biological aspects. Pathol Int 50:872–878

    Article  CAS  PubMed  Google Scholar 

  12. Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:165–171

    CAS  PubMed  Google Scholar 

  13. Fleming S, Lewi HJE (1986) Collecting duct carcinoma of the kidney. Histopathology 10:1131–1141

    Article  CAS  PubMed  Google Scholar 

  14. Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y (2008) Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 39:1350–1359

    Article  CAS  PubMed  Google Scholar 

  15. Kuroda N, Toi M, Hiroi M, Enzan H (2002) Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 17:1329–1334

    CAS  PubMed  Google Scholar 

  16. Armah HB, Parwani AV (2010) Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med 134:124–129

    PubMed  Google Scholar 

  17. Kuroda N, Mikami S, Pan CC, Cohen RJ, Hes O, Michal M, Nagashima Y, Tanaka Y, Inoue K, Shuin T, Lee GH (2012) Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 27:133–140

    PubMed  Google Scholar 

  18. Rakozy C, Schmahl GE, Bogner S, Störkel S (2002) Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 15:1162–1171

    Article  CAS  PubMed  Google Scholar 

  19. Kuroda N, Toi M, Hiroi M, Suin T, Enzan H (2005) Review of mucinous tubular and spindle-cell carcinoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 20:221–224

    CAS  PubMed  Google Scholar 

  20. Amin MB, Crotty TB, Tickoo SK, Farrow GM (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1–12

    Article  CAS  PubMed  Google Scholar 

  21. Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin S, Reuter VE (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21:871–883

    Article  CAS  PubMed  Google Scholar 

  22. Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:935–942

    CAS  PubMed  Google Scholar 

  23. Grignon DV, Eble JN (1998) Papillary and metanephric adenomas of the kidney. Semin Diagn Pathol 15:41–53

    CAS  PubMed  Google Scholar 

  24. Wade Strong J, Ro JY (1996) Metanephric adenoma of the kidney: a newly characterized entity. Adv Anat Pathol 3:172–178

    Article  Google Scholar 

  25. Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 18:253–257

    CAS  PubMed  Google Scholar 

  26. Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Troung LD (2005) Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29:443–451

    Article  PubMed  Google Scholar 

  27. Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141–153

    Article  PubMed  Google Scholar 

  28. Kuroda N, Ohe C, Mikami S, Hes O, Michal M, Brunelli M, Martignoni G, Sato Y, Yoshino T, Kakehi Y, Shuin T, Lee GH (2011) Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 26:1215–1218

    CAS  PubMed  Google Scholar 

  29. Kuroda N, Tamura M, Taguchi T, Tominaga A, Hes O, Michal M, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Shuin T, Lee GH (2008) Sarcomatoid acquired cystic disease-associated renal cell carcinoma. Histol Histopathol 23:1327–1331

    PubMed  Google Scholar 

  30. Kuroda N, Tamura M, Hamaguchi N, Mikami S, Pan CC, Brunelli M, Martignoni G, Hes O, Michal M, Lee GH (2011) Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 15:462–466

    Article  PubMed  Google Scholar 

  31. Ross H, Martignoni G, Argani P (2011) Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 136:391–399

    Article  Google Scholar 

  32. Kuroda N, Shiotsu T, Kawada C, Shuin T, Hes O, Michal M, Ohe C, Mikami S, Pan CC (2011) Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 15:282–285

    Article  PubMed  Google Scholar 

  33. Argani P, Hawkins A, Griffin CA, Goldstein JD, Haas M, Beckwith JB, Mankinen CB, Perlman EJ (2001) A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21;q12) chromosome translocation. Am J Pathol 158:2089–2096

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M (2005) Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29:230–240

    Article  PubMed  Google Scholar 

  35. Petersson F, Vaněček T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, Spagnolo D, Kuroda N, Yang XJ, Alvarado-Cabrero I, Hora M, Branžovský J, Trivunic S, Kacerovská D, Steiner P, Hes O (2012) A distinctive translocation of the kidney; “rosette forming”, t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol 43:726–736

    Article  CAS  PubMed  Google Scholar 

  36. Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430–442

    Article  CAS  PubMed  Google Scholar 

  37. Mariño-Enríquez A, Ou W-B, Weldon CB, Fletcher JA, Pérez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosom Cancer 5:146–153

    Article  Google Scholar 

  38. Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427–4436

    Article  CAS  PubMed  Google Scholar 

  39. Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC (2012) ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 25:1516–1525

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to doctors sending us some rare consultation cases.

Author information

Authors and Affiliations

  1. Department of Pathology, Kochi Red Cross Hospital, 2-13-51 Shin-honmachi, Kochi City, Kochi, 780-8561, Japan

    Naoto Kuroda & Azusa Tanaka

Authors
  1. Naoto Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azusa Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoto Kuroda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuroda, N., Tanaka, A. Recent classification of renal epithelial tumors. Med Mol Morphol 47, 68–75 (2014). https://doi.org/10.1007/s00795-013-0033-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-013-0033-0

Keywords

Search

Navigation